Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
July 18, 2015
Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
Yinan Zhang, Kevin Tianmeng Zhao, Susan G Fox, et al.
Journal of Medicinal Chemistry
|
December 24, 2011
ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Jinho Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 22, 2003
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
Xin Wang, Shan Zhu, Martin Drozda, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2006
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Hoon Ryu, Junghee Lee, Sean W Hagerty, et al.
Neurobiology of Disease
|
November 22, 2005
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
Peter Klivenyi, Donald Siwek, Gabrielle Gardian, et al.
Journal of Neurochemistry
|
September 2, 2005
Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease
Bruce G Jenkins, Ole A Andreassen, Alpaslan Dedeoglu, et al.
The Journal of Comparative Neurology
|
August 30, 2005
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice
Edward C Stack, James K Kubilus, Karen Smith, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 12, 2008
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J Del Signore, Daniel J Amante, Jinho Kim, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
July 18, 2015
Tertiary Amine Pyrazolones and Their Salts as Inhibitors of Mutant Superoxide Dismutase 1-Dependent Protein Aggregation for the Treatment of Amyotrophic Lateral Sclerosis
Yinan Zhang, Kevin Tianmeng Zhao, Susan G Fox, et al.
Journal of Medicinal Chemistry
|
December 24, 2011
ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Jinho Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 22, 2003
Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease
Xin Wang, Shan Zhu, Martin Drozda, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 5, 2006
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Hoon Ryu, Junghee Lee, Sean W Hagerty, et al.
Neurobiology of Disease
|
November 22, 2005
Mice lacking alpha-synuclein are resistant to mitochondrial toxins
Peter Klivenyi, Donald Siwek, Gabrielle Gardian, et al.
Journal of Neurochemistry
|
September 2, 2005
Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease
Bruce G Jenkins, Ole A Andreassen, Alpaslan Dedeoglu, et al.
The Journal of Comparative Neurology
|
August 30, 2005
Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice
Edward C Stack, James K Kubilus, Karen Smith, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
|
July 12, 2008
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice
Steven J Del Signore, Daniel J Amante, Jinho Kim, et al.
Bioorganic & Medicinal Chemistry
|
November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis
Tian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS"
Yinan Zhang, Radhia Benmohamed, Wei Zhang, et al.
Page
of 9